Anti-Mitofusin-2 Antibody, clone 2D19 ZooMAb^® Rabbit Monoclonal

rabbit

200

expressed in HEK 293 cells

unconjugated

purified antibody

primary antibodies

2D19, monoclonal
recombinant monoclonal

ZooMAb^® learn more

lyophilized

calculated mol wt ~ 86.4 kDa
observed mol wt ~ 79 kDa

rat, human, monkey

antibody small pack of 25 μL

recombinant expression
Learn more about Antibody Enhanced Validation

affinity binding assay: suitable
immunocytochemistry: suitable
western blot: suitable

IgG

ambient

2-8℃

ZooMAb antibodies represent an entirely new generation of recombinant monoclonal antibodies.

Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.

Clone 2D19 is a ZooMAb^® rabbit recombinant monoclonal antibody that specifically detects Mitofusin-2. It targets an epitope within 21 amino acids from the cytoplasmic domain in the C-terminal half.

KLH-conjugated linear peptide corresponding to 21 amino acids from the first cytoplasmic domain in the C-terminal region of human Mitofusin-2.

Quality Control Testing

Evaluated by Western Blotting in HeLa cell lysate.

Western Blotting Analysis: A 1:1,000 dilution of this antibody detected Mitofusin-2 in HeLa cell lysate.

Tested Applications

Western Blotting Analysis: A 1:1,000 dilution from a representative lot detected Mitofusin-2 in U2OS, COS-7, and PC12 cell lysates.

Immunocytochemistry Analysis: A 1:100 dilution from a representative detected Mitofusin-2 in HeLa cells.

Affinity Binding Assay: A representative lot of this antibody bound Mitofusin-2 peptides with a KD of 1.4 x 10-7 in an affinity binding assay.

Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Anti-Mitofusin-2, clone 2D19 ZooMAb^®, Cat. No. ZRB1202, is a recombinant Rabbit monoclonal antibody that specifically targets Mitofusin-2 and is tested for use in Affinity Binding Assay, Immunocytochemistry, and Western Blotting.

Purified recombinant mouse monoclonal antibody IgG, lyophilized in PBS, 5% Trehalose, normal appearance a coarse or translucent resin. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 μL.

300 μg/mL after reconstitution at 25 μL per vial. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany

Mitofusin-2 (UniProt: O95140; also known as Transmembrane GTPase MFN2) is encoded by the MFN2 (also known as CPRP1, KIAA0214) gene (Gene ID: 9927) in human. Mitofusin-1 and 2 are highly homologous mitochondrial proteins that display ~80% similarity in humans. Mitofusin-2 is a multi-pass membrane protein that serves as a mitochondrial outer membrane GTPase to mediate mitochondrial clustering and fusion. It is ubiquitously expressed at low level, but higher expression is observed in heart and kidney. It consists of a large, cytoplasmic N-terminal GTPase domain, followed by a spacer, a first coiled-coil heptad-repeat (HR1) domain, a spacer, two transmembrane domains that cross the outer mitochondrial membrane, a spacer and a second, C-terminal heptad-repeat domain (HR2). Between HR1 and transmembrane domains, it contains a proline-rich domain that participates in protein protein interactions. Mitofusin-2 plays a key role in mitochondrial metabolism and is involved in mitochondrial fusion, trafficking, turnover, contacts with other organelles, and in the clearance of damaged mitochondria via selective mitophagy. Mitofusin-2 is phosphorylated by PINK1 and the phosphorylated form functions as a receptor for parkin that mediates its ubiquitination, a signal to mark damaged mitochondria. It is also required in the control of unfolded protein response upon endoplasmic reticulum stress. Mitofusion-2 knockout cells display mitochondrial spheres or ovals of different sizes and are several folds larger in diameter than wild-type. Mutations in MFN2 gene are known to cause Charcot-Marie-Tooth disease that is characterized by signs of axonal degeneration and progressive distal muscle weakness and atrophy. This ZooMAb^® recombinant monoclonal antibody, generated by our propriety technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals. (Ref.: Filadi, R., et al. (2018). Cell Death Dis. 9; Article 330).

Recommend storage of lyophilized product at 2-8℃; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 μL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8℃, or -20℃ for long term storage. Avoid repeated freeze-thaws.

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

11 - Combustible Solids

WGK 1